1887
Surveillance Open Access
Like 0

Abstract

Background

New Delhi metallo-beta-lactamase (NDM)-producing has been reported from European Union/European Economic Area (EU/EEA) countries with increasing frequency. During 2018 to 2022, 355 cases of NDM-producing were detected in seven hospitals reporting on NDM-production in Enterobacterales in Romania.

Aim

Our aim was to determine the extent of spread of NDM-producing in hospitals in Romania.

Methods

We analysed whole genome sequences and epidemiological data of 74 isolates collected in six hospitals from December 2021 to September 2023.

Results

We identified four multi-hospital clusters including isolates detected over more than a year, indicating sustained spread of -carrying within the healthcare system. These clusters consisted of isolates from up to four hospitals and three regions. Three multi-hospital clusters were caused by a specific multidrug-resistant sequence type 46 lineage carrying and a large set of additional resistance markers. Investigation in an international context showed that this lineage had already been detected in nine countries (Bulgaria, France, Germany, Ireland, the Netherlands, Romania, Switzerland, United Kingdom, United States) since 2015.

Conclusion

Our results alert about the risk of carbapenem-resistant transmission in healthcare settings. Enhanced infection prevention and control measures should be instituted as soon as cases are detected in healthcare facilities. National surveillance systems in EU/EEA countries should, in addition to carbapenem-resistant and/or carbapenemase-producing and , consider reporting carbapenem-resistant and/or carbapenemase-producing and other Enterobacterales where relevant.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2024.29.47.2400587
2024-11-21
2024-11-25
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2024.29.47.2400587
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/29/47/eurosurv-29-47-4.html?itemId=/content/10.2807/1560-7917.ES.2024.29.47.2400587&mimeType=html&fmt=ahah

References

  1. Grundmann H, Glasner C, Albiger B, Aanensen DM, Tomlinson CT, Andrasević AT, et al. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. Lancet Infect Dis. 2017;17(2):153-63.  https://doi.org/10.1016/S1473-3099(16)30257-2  PMID: 27866944 
  2. European Centre for Disease Prevention and Control (ECDC). ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level - version 2.0. Stockholm: ECDC; 2018. Available from: https://ecdc.europa.eu/en/publications-data/ecdc-study-protocol-genomic-based-surveillance-carbapenem-resistant-andor
  3. Witteveen S, Hans JB, Izdebski R, Hasman H, Samuelsen Ø, Dortet L, et al. Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Euro Surveill. 2024;29(23):2300616.  https://doi.org/10.2807/1560-7917.ES.2024.29.23.2300616  PMID: 38847120 
  4. Molnár S, Flonta MMM, Almaş A, Buzea M, Licker M, Rus M, et al. Dissemination of NDM-1 carbapenemase-producer Providencia stuartii strains in Romanian hospitals: a multicentre study. J Hosp Infect. 2019;103(2):165-9.  https://doi.org/10.1016/j.jhin.2019.04.015  PMID: 31039380 
  5. European Committee for Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and zone diameters, version 14.0, valid from 2024-01-01. Växjö: EUCAST; 2024. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_14.0_Breakpoint_Tables.pdf
  6. Silva M, Machado MP, Silva DN, Rossi M, Moran-Gilad J, Santos S, et al. chewBBACA: A complete suite for gene-by-gene schema creation and strain identification. Microb Genom. 2018;4(3):e000166.  https://doi.org/10.1099/mgen.0.000166  PMID: 29543149 
  7. Juneja P, Lazzaro BP. Providencia sneebia sp. nov. and Providencia burhodogranariea sp. nov., isolated from wild Drosophila melanogaster. Int J Syst Evol Microbiol. 2009;59(Pt 5):1108-11.  https://doi.org/10.1099/ijs.0.000117-0  PMID: 19406801 
  8. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.  https://doi.org/10.12688/wellcomeopenres.14826.1  PMID: 30345391 
  9. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75(12):3491-500.  https://doi.org/10.1093/jac/dkaa345  PMID: 32780112 
  10. Carattoli A, Zankari E, García-Fernández A, Voldby Larsen M, Lund O, Villa L, et al. In silico detection and typing of plasmids using PlasmidFinder and plasmid multilocus sequence typing. Antimicrob Agents Chemother. 2014;58(7):3895-903.  https://doi.org/10.1128/AAC.02412-14  PMID: 24777092 
  11. Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, et al. BLAST+: architecture and applications. BMC Bioinformatics. 2009;10(1):421.  https://doi.org/10.1186/1471-2105-10-421  PMID: 20003500 
  12. Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J, Glasner C, et al. Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom. 2016;2(11):e000093.  https://doi.org/10.1099/mgen.0.000093  PMID: 28348833 
  13. Capitani V, Arcari G, Oliva A, Sacco F, Menichincheri G, Fenske L, et al. Genome-based retrospective analysis of a Providencia stuartii outbreak in Rome, Italy: broad spectrum IncC plasmids spread the NDM carbapenemase within the hospital. Antibiotics (Basel). 2023;12(5):943.  https://doi.org/10.3390/antibiotics12050943  PMID: 37237846 
  14. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81.  https://doi.org/10.1111/j.1469-0691.2011.03570.x  PMID: 21793988 
  15. Leclercq R, Cantón R, Brown DF, Giske CG, Heisig P, MacGowan AP, et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin Microbiol Infect. 2013;19(2):141-60.  https://doi.org/10.1111/j.1469-0691.2011.03703.x  PMID: 22117544 
  16. European Committee for Antimicrobial Susceptibility Testing (EUCAST). EUCAST guidance on use of fosfomycin i.v. breakpoints. Växjö: EUCAST; 2024. Available from: https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Guidance_documents/Use_of_fosfomycin_iv_breakpoints_General_advice_20240528.pdf
  17. Moser AI, Keller PM, Campos-Madueno EI, Poirel L, Nordmann P, Endimiani A. A patient with multiple carbapenemase producers including an unusual Citrobacter sedlakii hosting an IncC bla NDM-1- and armA-carrying plasmid. Pathog Immun. 2021;6(2):119-34.  https://doi.org/10.20411/pai.v6i2.482  PMID: 34988342 
  18. Sabtcheva S, Stoikov I, Ivanov IN, Donchev D, Lesseva M, Georgieva S, et al. Genomic characterization of carbapenemase-producing Enterobacter hormaechei, Serratia marcescens, Citrobacter freundii, Providencia stuartii, and Morganella morganii clinical isolates from Bulgaria. Antibiotics (Basel). 2024;13(5):455.  https://doi.org/10.3390/antibiotics13050455  PMID: 38786183 
  19. Rezzoug I, Emeraud C, Girlich D, Creton E, Naas T, Bonnin RA, et al. Characterization of VIM-29 and VIM-86, two VIM-1 variants isolated in multidrug-resistant Enterobacterales in France. J Antimicrob Chemother. 2024;79(3):683-5.  https://doi.org/10.1093/jac/dkad400  PMID: 38197500 
  20. Pirii LE, Friedrich AW, Rossen JWA, Vogels W, Beerthuizen GIJM, Nieuwenhuis MK, et al. Extensive colonization with carbapenemase-producing microorganisms in Romanian burn patients: infectious consequences from the Colectiv fire disaster. Eur J Clin Microbiol Infect Dis. 2018;37(1):175-83.  https://doi.org/10.1007/s10096-017-3118-1  PMID: 29063446 
  21. Manageiro V, Sampaio DA, Pereira P, Rodrigues P, Vieira L, Palos C, et al. Draft genome sequence of the first NDM-1-producing Providencia stuartii strain isolated in Portugal. Genome Announc. 2015;3(5):e01077-15.  https://doi.org/10.1128/genomeA.01077-15  PMID: 26404603 
  22. Peirano G, Chen L, Kreiswirth BN, Pitout JDD. Emerging antimicrobial-resistant high-risk Klebsiella pneumoniae clones ST307 and ST147. Antimicrob Agents Chemother. 2020;64(10):e01148-20.  https://doi.org/10.1128/AAC.01148-20  PMID: 32747358 
  23. McGann P, Hang J, Clifford RJ, Yang Y, Kwak YI, Kuschner RA, et al. Complete sequence of a novel 178-kilobase plasmid carrying bla(NDM-1) in a Providencia stuartii strain isolated in Afghanistan. Antimicrob Agents Chemother. 2012;56(4):1673-9.  https://doi.org/10.1128/AAC.05604-11  PMID: 22290972 
  24. Oikonomou O, Liakopoulos A, Phee LM, Betts J, Mevius D, Wareham DW. Providencia stuartii isolates from Greece: co-carriage of cephalosporin (blaSHV-5, blaVEB-1), carbapenem (blaVIM-1), and aminoglycoside (rmtB) resistance determinants by a multidrug-resistant outbreak clone. Microb Drug Resist. 2016;22(5):379-86.  https://doi.org/10.1089/mdr.2015.0215  PMID: 27380549 
  25. Camargo CH, Yamada AY, de Souza AR, Sacchi CT, Reis AD, Santos MBN, et al. Genomic characterization of New Delhi metallo-beta-lactamase-producing species of Morganellaceae, Yersiniaceae, and Enterobacteriaceae (other than Klebsiella) from Brazil over 2013-2022. Microbiol Immunol. 2024;68(1):1-5.  https://doi.org/10.1111/1348-0421.13100  PMID: 37859304 
  26. Tijet N, Richardson D, MacMullin G, Patel SN, Melano RG. Characterization of multiple NDM-1-producing Enterobacteriaceae isolates from the same patient. Antimicrob Agents Chemother. 2015;59(6):3648-51.  https://doi.org/10.1128/AAC.04862-14  PMID: 25845877 
  27. Soliman AM, Zarad HO, Nariya H, Shimamoto T, Shimamoto T. Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt. Infect Genet Evol. 2020;77:104065.  https://doi.org/10.1016/j.meegid.2019.104065  PMID: 31634643 
  28. Sharma S, Pramanik S, Marndi P, Banerjee T. Hospital-acquired infections due to carbapenem-resistant Providencia stuartii. Indian J Med Res. 2023;158(2):145-50.  https://doi.org/10.4103/ijmr.IJMR_3668_20  PMID: 37787258 
  29. Rao J, Stornelli NK, Everson NA, McDaniel LF, Gomez De La Espriella M, Faulhaber JR, et al. Complete genome sequence of Providencia stuartii CMC-4104, isolated from a human splenic abscess, containing multiple copies of NDM-1 and PER-1 carbapenem resistance genes. Microbiol Resour Announc. 2022;11(9):e0051422.  https://doi.org/10.1128/mra.00514-22  PMID: 35924937 
  30. Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, Brisse S, Doumith M, Woodford N, et al. . Molecular and epidemiological characterization of carbapenemase-producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One. 2017;12(11):e0187832.  https://doi.org/10.1371/journal.pone.0187832  PMID: 29141051 
/content/10.2807/1560-7917.ES.2024.29.47.2400587
Loading

Data & Media loading...

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error